ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma08/12/2025PR Newswire
RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION08/12/2025PR Newswire
AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore08/12/2025PR Newswire
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting08/12/2025PR Newswire
ProstACT Global Phase 3 Update: First Patient Dosed in Randomized Treatment Expansion, Part 1 Readout Plans Confirmed08/12/2025PR Newswire
Strutt ev¹ ยานพาหนะส่วนบุคคลอัจฉริยะที่คว้ารางวัล CES 2026 Best of Innovation เปิดพรีออเดอร์รอบ Super Early Bird แล้ว08/12/2025PR Newswire
งานมหกรรมห่วงโซ่อุปทานนานาชาติจีน ครั้งที่ 4 มีกำหนดจัดขึ้นที่กรุงปักกิ่งในเดือนมิถุนายน 256908/12/2025PR Newswire
CARsgen’s CAR-T Product Zevor-Cel Included in China’s Commercial Health Insurance Innovative Drug Catalogue07/12/2025PR Newswire
All Approved Indications of Five Akeso’s Innovative Drugs Included in China’s Latest NRDL: Featuring Two First-in-Class Bispecifics with New First-Line Indications and Three Newly Negotiated Drugs07/12/2025PR Newswire
Skymizerʼs HyperThought™ Wins “Best IP/Processor of the Yearˮ and “Most Promising Productˮ at EE Awards Asia 202507/12/2025PR Newswire
